166 related articles for article (PubMed ID: 32916295)
1. Renal denervation vascular effects: An "insider's" view.
Dimitriadis K; Tsioufis C
Hellenic J Cardiol; 2020; 61(3):197-198. PubMed ID: 32916295
[TBL] [Abstract][Full Text] [Related]
2. The safety of renal denervation as assessed by optical coherence tomography: pre- and post-procedure comparison with multi-electrode ablation catheter in animal experiment.
Han W; Guan S; Gan Q; Zhai X; Wang M; Qu X
Hellenic J Cardiol; 2020; 61(3):190-196. PubMed ID: 30684647
[TBL] [Abstract][Full Text] [Related]
3. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
Lauder L; Ewen S; Tzafriri AR; Edelman ER; Cremers B; Kulenthiran S; Ukena C; Linz D; Kindermann I; Tsioufis C; Scheller B; Böhm M; Mahfoud F
Cardiovasc Revasc Med; 2018; 19(7 Pt B):845-851. PubMed ID: 29555535
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of renal arteries after radio-frequency catheter-based denervation using optical coherence tomography and angiography.
Roleder T; Skowerski M; Wiecek A; Adamczak M; Czerwienska B; Wanha W; Jadczyk T; Partyka L; Smolka G; Kuczmik W; Ochała A; Dudek D; Tendera M; Gasior Z; Wojakowski W
Int J Cardiovasc Imaging; 2016 Jun; 32(6):855-62. PubMed ID: 26883432
[TBL] [Abstract][Full Text] [Related]
5. Safety and Clinical Outcome of the Delivery of Radiofrequency Nerve Ablation Therapy in a Renal Artery of Unusual Anatomy.
de Leon-Martinez EP; Garza JA; Azpiri-Lopez JR; Dillon KN; Salazar LO; Canepa-Campos F; Rousselle SD; Tellez A
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):445-8. PubMed ID: 26014838
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in renal denervation devices for resistant hypertension treatment.
Haribabu S; Sharif F; Zafar H
Ir J Med Sci; 2021 Aug; 190(3):971-979. PubMed ID: 33111251
[TBL] [Abstract][Full Text] [Related]
7. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
Ghadri JR; Gaehwiler R; Jaguszewski M; Sudano I; Osipova J; Schoenenberger-Berzins R; Erne P; Lüscher TF; Templin C
Swiss Med Wkly; 2015; 145():w14102. PubMed ID: 25658048
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension.
Mahfoud F; Sievert H; Bertog S; Lauder L; Ewen S; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Weber MA; Kandzari DE; Parise H; Fischell TA; Pathak A; Persu A
Circ Cardiovasc Interv; 2021 Sep; 14(9):e010075. PubMed ID: 34470501
[TBL] [Abstract][Full Text] [Related]
9. Renal denervation as a management strategy for hypertension: current evidence and recommendations.
Kiuchi MG; Carnagarin R; Nolde JM; Lugo-Gavidia LM; Ward NC; Schlaich MP
Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):825-835. PubMed ID: 34353197
[TBL] [Abstract][Full Text] [Related]
10. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging.
Schmid A; Schmieder R; Lell M; Janka R; Veelken R; Schmieder RE; Uder M; Ott C
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):426-32. PubMed ID: 26253780
[TBL] [Abstract][Full Text] [Related]
11. Catheter-based renal denervation in hypertension: heading for new shores.
Mahfoud F; Böhm M; Edelman ER
J Hypertens; 2018 Jan; 36(1):41-42. PubMed ID: 29210859
[No Abstract] [Full Text] [Related]
12. Renal Denervation in the Treatment of Resistant Hypertension and Difficult-to-Control Hypertension - Consensus Document of the Croatian Hypertension League - Croatian Society of Hypertension, Croatian Cardiac Society, Croatian Endovascular Initiative, Croatian Society for Diabetes and Metabolic Diseases, Croatian Renal Association, and Croatian Society of Family Physicians of the Croatian Medical Association.
Jelaković B; Perkov D; Barišić K; Bukal N; Gellineo L; Jelaković A; Josipović J; Prkačin I; Željković Vrkić T; Živko M;
Vasc Health Risk Manag; 2023; 19():805-826. PubMed ID: 38108022
[TBL] [Abstract][Full Text] [Related]
13. The effect of two different renal denervation strategies on blood pressure in resistant hypertension: Comparison of full-length versus proximal renal artery ablation.
Chen W; Ling Z; Du H; Song W; Xu Y; Liu Z; Su L; Xiao P; Yuan Y; Lu J; Zhang J; Li Z; Shao J; Zhong B; Zhou B; Woo K; Yin Y
Catheter Cardiovasc Interv; 2016 Nov; 88(5):786-795. PubMed ID: 27219520
[TBL] [Abstract][Full Text] [Related]
14. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
[TBL] [Abstract][Full Text] [Related]
15. Early morphologic alterations in renal artery wall and renal nerves in response to catheter-based renal denervation procedure in sheep: difference between single-point and multiple-point ablation catheters.
Táborský M; Richter D; Tonar Z; Kubíková T; Herman A; Peregrin J; Červenková L; Husková Z; Kopkan L
Physiol Res; 2017 Sep; 66(4):601-614. PubMed ID: 28406699
[TBL] [Abstract][Full Text] [Related]
16. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN multi-electrode renal denervation catheter.
Templin C; Jaguszewski M; Ghadri JR; Sudano I; Gaehwiler R; Hellermann JP; Schoenenberger-Berzins R; Landmesser U; Erne P; Noll G; Lüscher TF
Eur Heart J; 2013 Jul; 34(28):2141-8, 2148b. PubMed ID: 23620498
[TBL] [Abstract][Full Text] [Related]
17. Renal sympathetic denervation in a previously stented renal artery.
Berra E; Rabbia F; Rossato D; Covella M; Totaro S; Chiara F; Di Monaco S; Veglio F
J Clin Hypertens (Greenwich); 2014 Mar; 16(3):238-9. PubMed ID: 24387740
[No Abstract] [Full Text] [Related]
18. Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.
Weber MA; Mahfoud F; Schmieder RE; Kandzari DE; Tsioufis KP; Townsend RR; Kario K; Böhm M; Sharp ASP; Davies JE; Osborn JW; Fink GD; Euler DE; Cohen DL; Schlaich MP; Esler MD
JACC Cardiovasc Interv; 2019 Jun; 12(12):1095-1105. PubMed ID: 31221299
[TBL] [Abstract][Full Text] [Related]
19. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.
Ojrzanowski M; Kasprzak JD; Peruga JZ; Kurpesa M; Jankowski Ł; Sahni S; Plewka M
Adv Clin Exp Med; 2019 Nov; 28(11):1525-1530. PubMed ID: 31693316
[TBL] [Abstract][Full Text] [Related]
20. Comparison of ablation characteristics of three different radiofrequency applicators in renal sympathetic denervation.
Cheng Y; Liu H; Tian Z; Zhang M; Liu Y; Nan Q
Int J Hyperthermia; 2021; 38(1):1251-1262. PubMed ID: 34404307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
